(Reuters) -GSK has agreed to pay up to $2.2 billion to settle most lawsuits in U.S. state courts claiming that a discontinued ...
GSK has agreed to pay up to $2.2 billion to resolve approximately 80,000 lawsuits brought by users of Zantac who claimed the heartburn drug caused their cancer. The agreement frees the British ...
After protracted legal battling, GSK has agreed to pay up to $2.2 billion to settle most of the pending lawsuits that claimed a discontinued version of the Zantac heartburn medication caused cancer.
The lawsuits arose after recipients of GSK’s heartburn drug Zantac claimed it caused cancer. Chief executive Emma Walmsey said the move to settle around 80,000 lawsuits across the US – covering about ...
If you or a loved one took Zantac (ranitidine) and later developed health complications, particularly cancer, you may be ...
(RTTNews) - GSK plc (GSK.L) reported that its third quarter ... reflecting a charge of 1.8 billion pounds or $2.3 billion in relation to the Zantac settlement. Loss attributable to shareholders ...
Walmart has agreed to pay $7.5 million to settle a lawsuit filed by California officials that alleged the retail giant illegally dumped hazardous waste SAN FRANCISCO -- Walmart has agreed to pay $ ...
GSK has reached agreements with 10 plaintiff firms to settle around 80,000 state court product liability cases related to its heartburn medication, Zantac, for $2.2 billion. The agreements involve ...
Oct 9 (Reuters) - GSK has agreed to pay up to $2.2 billion to settle most lawsuits in U.S. state courts claiming that a discontinued version of the heartburn drug Zantac caused cancer, the company ...